Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis C, Chronic | 12 | 2024 | 64 | 1.930 |
Why?
|
| Hepatitis B, Chronic | 5 | 2023 | 27 | 1.450 |
Why?
|
| Hepatitis C | 7 | 2023 | 65 | 1.260 |
Why?
|
| Antiviral Agents | 12 | 2024 | 95 | 1.210 |
Why?
|
| Liver Cirrhosis | 6 | 2024 | 34 | 0.820 |
Why?
|
| Sustained Virologic Response | 6 | 2023 | 17 | 0.750 |
Why?
|
| Humans | 52 | 2024 | 18430 | 0.690 |
Why?
|
| Quality of Life | 4 | 2023 | 529 | 0.650 |
Why?
|
| Female | 41 | 2024 | 13136 | 0.640 |
Why?
|
| Stress, Psychological | 1 | 2020 | 147 | 0.630 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2023 | 26 | 0.590 |
Why?
|
| Hawaii | 12 | 2023 | 45 | 0.590 |
Why?
|
| Health Status | 1 | 2020 | 328 | 0.590 |
Why?
|
| Suicide | 3 | 2024 | 126 | 0.580 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 42 | 0.580 |
Why?
|
| Male | 27 | 2024 | 10440 | 0.510 |
Why?
|
| Hepacivirus | 9 | 2024 | 51 | 0.510 |
Why?
|
| Mental Disorders | 3 | 2022 | 295 | 0.470 |
Why?
|
| Patient Health Questionnaire | 2 | 2024 | 18 | 0.460 |
Why?
|
| Adult | 21 | 2024 | 7910 | 0.460 |
Why?
|
| Middle Aged | 23 | 2024 | 8284 | 0.450 |
Why?
|
| Cataract Extraction | 1 | 2012 | 3 | 0.410 |
Why?
|
| Cataract | 1 | 2012 | 10 | 0.410 |
Why?
|
| Rural Population | 1 | 2012 | 52 | 0.400 |
Why?
|
| Adolescent | 20 | 2024 | 3798 | 0.390 |
Why?
|
| United States | 13 | 2024 | 4164 | 0.380 |
Why?
|
| Prevalence | 5 | 2023 | 911 | 0.380 |
Why?
|
| Aged | 15 | 2024 | 6417 | 0.370 |
Why?
|
| Coinfection | 2 | 2023 | 30 | 0.360 |
Why?
|
| Hepatitis B | 2 | 2023 | 43 | 0.360 |
Why?
|
| Mental Health | 2 | 2023 | 168 | 0.350 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 2 | 2022 | 12 | 0.350 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 2 | 2007 | 4 | 0.340 |
Why?
|
| Risk Factors | 10 | 2022 | 3449 | 0.340 |
Why?
|
| Diet | 3 | 2007 | 371 | 0.340 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 259 | 0.330 |
Why?
|
| Retrospective Studies | 8 | 2024 | 2550 | 0.320 |
Why?
|
| Absorptiometry, Photon | 4 | 2011 | 52 | 0.300 |
Why?
|
| Cohort Studies | 12 | 2024 | 2672 | 0.290 |
Why?
|
| Self-Injurious Behavior | 2 | 2024 | 44 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 760 | 0.280 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2006 | 7 | 0.270 |
Why?
|
| Feeding Behavior | 2 | 2007 | 168 | 0.260 |
Why?
|
| Breast Neoplasms | 5 | 2017 | 1037 | 0.250 |
Why?
|
| Hepatitis B virus | 3 | 2023 | 21 | 0.250 |
Why?
|
| Clozapine | 1 | 2024 | 5 | 0.240 |
Why?
|
| Aminoisobutyric Acids | 1 | 2024 | 2 | 0.230 |
Why?
|
| Cyclopropanes | 1 | 2024 | 2 | 0.230 |
Why?
|
| Lactams, Macrocyclic | 1 | 2024 | 2 | 0.230 |
Why?
|
| Leucine | 1 | 2024 | 3 | 0.230 |
Why?
|
| Benzimidazoles | 1 | 2024 | 6 | 0.230 |
Why?
|
| Proline | 1 | 2024 | 5 | 0.230 |
Why?
|
| Sulfonamides | 1 | 2024 | 14 | 0.230 |
Why?
|
| Body Mass Index | 4 | 2022 | 974 | 0.230 |
Why?
|
| Adipose Tissue | 5 | 2011 | 60 | 0.230 |
Why?
|
| Obesity | 3 | 2024 | 855 | 0.230 |
Why?
|
| Psychotic Disorders | 1 | 2024 | 47 | 0.230 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 57 | 0.230 |
Why?
|
| ras Proteins | 2 | 2014 | 24 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 36 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2023 | 10 | 0.220 |
Why?
|
| Latent Tuberculosis | 1 | 2023 | 10 | 0.220 |
Why?
|
| Opportunistic Infections | 1 | 2022 | 8 | 0.210 |
Why?
|
| Ribavirin | 2 | 2019 | 8 | 0.210 |
Why?
|
| African Americans | 3 | 2020 | 490 | 0.210 |
Why?
|
| Breast | 3 | 2011 | 84 | 0.200 |
Why?
|
| Carbonated Beverages | 3 | 2007 | 14 | 0.200 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 159 | 0.190 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 598 | 0.190 |
Why?
|
| Surveys and Questionnaires | 4 | 2022 | 1389 | 0.190 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 320 | 0.190 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 211 | 0.190 |
Why?
|
| Weight Gain | 1 | 2022 | 181 | 0.190 |
Why?
|
| Young Adult | 7 | 2024 | 2518 | 0.180 |
Why?
|
| Psychology | 1 | 2020 | 17 | 0.180 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 2 | 0.180 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 2 | 0.180 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 2 | 0.180 |
Why?
|
| Overweight | 1 | 2022 | 276 | 0.180 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 164 | 0.180 |
Why?
|
| Unemployment | 1 | 2020 | 11 | 0.180 |
Why?
|
| Psychiatry | 1 | 2020 | 23 | 0.180 |
Why?
|
| Physician's Role | 1 | 2020 | 32 | 0.180 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 19 | 0.170 |
Why?
|
| Incidence | 5 | 2022 | 1314 | 0.160 |
Why?
|
| Puberty | 2 | 2011 | 58 | 0.160 |
Why?
|
| China | 2 | 2024 | 130 | 0.160 |
Why?
|
| Prospective Studies | 5 | 2023 | 1314 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2024 | 1296 | 0.160 |
Why?
|
| Social Support | 1 | 2020 | 214 | 0.160 |
Why?
|
| Virus Activation | 1 | 2018 | 6 | 0.150 |
Why?
|
| Mental Health Services | 1 | 2020 | 161 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 54 | 0.150 |
Why?
|
| Time Factors | 5 | 2019 | 1136 | 0.150 |
Why?
|
| Comorbidity | 1 | 2020 | 619 | 0.150 |
Why?
|
| Neoplasms | 1 | 2022 | 457 | 0.150 |
Why?
|
| Liver | 1 | 2017 | 33 | 0.150 |
Why?
|
| Gene Library | 1 | 2017 | 3 | 0.150 |
Why?
|
| Paraffin Embedding | 1 | 2017 | 6 | 0.150 |
Why?
|
| Child | 8 | 2023 | 2571 | 0.150 |
Why?
|
| Calcium, Dietary | 3 | 2007 | 28 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 630 | 0.150 |
Why?
|
| Risk Assessment | 5 | 2024 | 1143 | 0.140 |
Why?
|
| Suicidal Ideation | 3 | 2024 | 100 | 0.140 |
Why?
|
| Pregnancy | 1 | 2022 | 1516 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2017 | 17 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 38 | 0.140 |
Why?
|
| Suicide, Attempted | 1 | 2018 | 98 | 0.140 |
Why?
|
| Health Policy | 1 | 2018 | 136 | 0.140 |
Why?
|
| Tuberculosis | 1 | 2017 | 20 | 0.140 |
Why?
|
| Menarche | 2 | 2009 | 30 | 0.140 |
Why?
|
| Colorectal Neoplasms | 2 | 2014 | 656 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 407 | 0.140 |
Why?
|
| Viral Load | 1 | 2017 | 135 | 0.140 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2017 | 57 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2018 | 271 | 0.140 |
Why?
|
| Sex Distribution | 2 | 2017 | 198 | 0.130 |
Why?
|
| Age Distribution | 2 | 2017 | 261 | 0.130 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 1360 | 0.130 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 2003 | 0.120 |
Why?
|
| Cause of Death | 3 | 2021 | 185 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 2012 | 7 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 7 | 0.110 |
Why?
|
| Age Factors | 4 | 2019 | 965 | 0.110 |
Why?
|
| Skinfold Thickness | 3 | 2006 | 18 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2015 | 267 | 0.100 |
Why?
|
| Minority Groups | 2 | 2023 | 105 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2012 | 167 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 624 | 0.090 |
Why?
|
| Iron, Dietary | 2 | 2007 | 7 | 0.090 |
Why?
|
| Heart Failure | 1 | 2015 | 398 | 0.080 |
Why?
|
| Dietary Fiber | 2 | 2007 | 60 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2022 | 1173 | 0.080 |
Why?
|
| Depression | 2 | 2024 | 518 | 0.080 |
Why?
|
| Asian Americans | 2 | 2020 | 182 | 0.070 |
Why?
|
| Nutritional Requirements | 1 | 2007 | 6 | 0.070 |
Why?
|
| Body Fat Distribution | 1 | 2007 | 5 | 0.070 |
Why?
|
| Dietary Sucrose | 1 | 2007 | 12 | 0.070 |
Why?
|
| Nutrition Policy | 1 | 2007 | 18 | 0.070 |
Why?
|
| Skin | 1 | 2007 | 14 | 0.070 |
Why?
|
| Sunlight | 1 | 2007 | 16 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2007 | 22 | 0.070 |
Why?
|
| Vitamin D | 1 | 2007 | 80 | 0.070 |
Why?
|
| Asia | 1 | 2006 | 15 | 0.070 |
Why?
|
| Survival Rate | 2 | 2020 | 269 | 0.070 |
Why?
|
| European Continental Ancestry Group | 2 | 2020 | 554 | 0.070 |
Why?
|
| Folic Acid | 1 | 2006 | 35 | 0.070 |
Why?
|
| Diet Surveys | 1 | 2006 | 58 | 0.070 |
Why?
|
| Smoking | 2 | 2022 | 494 | 0.070 |
Why?
|
| California | 2 | 2023 | 2365 | 0.060 |
Why?
|
| Milk | 1 | 2004 | 8 | 0.060 |
Why?
|
| Smoke | 1 | 2024 | 6 | 0.060 |
Why?
|
| Pyrrolidines | 1 | 2024 | 2 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2018 | 724 | 0.060 |
Why?
|
| Pruritus | 1 | 2023 | 3 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2024 | 12 | 0.060 |
Why?
|
| Bone Density | 1 | 2004 | 96 | 0.060 |
Why?
|
| Infant Formula | 1 | 2003 | 11 | 0.060 |
Why?
|
| Fatigue | 1 | 2023 | 35 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2024 | 79 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 25 | 0.060 |
Why?
|
| Genotype | 1 | 2024 | 253 | 0.060 |
Why?
|
| Logistic Models | 2 | 2019 | 962 | 0.060 |
Why?
|
| Population Groups | 1 | 2023 | 8 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 743 | 0.060 |
Why?
|
| Body Weight | 1 | 2004 | 223 | 0.060 |
Why?
|
| Mutation | 2 | 2014 | 132 | 0.050 |
Why?
|
| Health Promotion | 1 | 2006 | 294 | 0.050 |
Why?
|
| Genetic Testing | 2 | 2014 | 89 | 0.050 |
Why?
|
| Child Health | 1 | 2023 | 34 | 0.050 |
Why?
|
| Exercise | 2 | 2004 | 495 | 0.050 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2022 | 7 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2007 | 319 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2020 | 7 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 14 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 22 | 0.040 |
Why?
|
| Bilirubin | 1 | 2020 | 30 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2020 | 69 | 0.040 |
Why?
|
| Oceanic Ancestry Group | 1 | 2020 | 33 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 269 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 64 | 0.040 |
Why?
|
| Mammography | 2 | 2011 | 174 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 5 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 119 | 0.040 |
Why?
|
| Washington | 1 | 2020 | 388 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 45 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 701 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2023 | 1478 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 847 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 49 | 0.040 |
Why?
|
| Glycated Hemoglobin A | 1 | 2019 | 233 | 0.040 |
Why?
|
| Fibrosis | 1 | 2017 | 7 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2018 | 109 | 0.040 |
Why?
|
| Hispanic Americans | 1 | 2020 | 428 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 4 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2017 | 43 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 346 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 162 | 0.030 |
Why?
|
| Ethnic Groups | 1 | 2020 | 501 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 673 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 308 | 0.030 |
Why?
|
| Health Behavior | 1 | 2018 | 374 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1269 | 0.030 |
Why?
|
| Body Composition | 2 | 2007 | 82 | 0.030 |
Why?
|
| Pacific States | 1 | 2015 | 4 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 661 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 690 | 0.030 |
Why?
|
| Educational Status | 1 | 2015 | 205 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2015 | 53 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 33 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 90 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 150 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 337 | 0.030 |
Why?
|
| Continental Population Groups | 1 | 2015 | 315 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2019 | 848 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 100 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 131 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 65 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2012 | 253 | 0.030 |
Why?
|
| Family Health | 1 | 2011 | 49 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 237 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 321 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 399 | 0.020 |
Why?
|
| Mothers | 1 | 2011 | 110 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2012 | 256 | 0.020 |
Why?
|
| Polynesia | 1 | 2009 | 1 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2007 | 23 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2007 | 20 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2007 | 27 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 51 | 0.020 |
Why?
|
| Diet Records | 1 | 2007 | 36 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 8 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2007 | 92 | 0.020 |
Why?
|
| Energy Intake | 1 | 2007 | 103 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2007 | 115 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2004 | 63 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2004 | 96 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 46 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 261 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 67 | 0.010 |
Why?
|
| Aging | 1 | 2003 | 165 | 0.010 |
Why?
|
| Breast Feeding | 1 | 2003 | 133 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2003 | 872 | 0.010 |
Why?
|
Concepts
(243)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->